A Mass Balance Study of [14C] SHR6508 in Chinese Hemodialysis Subjects With Secondary Hyperparathyroidism
Clinical trial NCT06877247 · COMPLETED
Trial details
- NCT number
- NCT06877247
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-23
- Primary completion
- 2025-04-04
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.